Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
45
CLPHY Quote, Financials, Valuation and Earnings
Last price:
$8.20
Seasonality move
:
1.92%
Day range:
$7.89 - $8.53
52-week range:
$7.57 - $9.54
Dividend yield:
4.84%
P/E ratio:
21.44x
P/S ratio:
1.84x
P/B ratio:
1.51x
Volume:
420.2K
Avg. volume:
217.7K
1-year change:
3.67%
Market cap:
$20.7B
Revenue:
$11.1B
EPS (TTM):
$0.38
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.9B | $10.3B | $10.8B | $12.9B | $11.1B | |
| Revenue Growth (YoY) | -6.25% | -6.18% | 5.27% | 19.01% | -13.38% | |
| Cost of Revenues | $7.5B | $6.6B | $7.4B | $10.4B | $7.5B | |
| Gross Profit | $3.4B | $3.6B | $3.4B | $2.4B | $3.6B | |
| Gross Profit Margin | 31.14% | 35.23% | 31.71% | 18.73% | 32.73% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.6B | $1.7B | $1.9B | $1.7B | $1.7B | |
| Operating Income | $1.8B | $1.9B | $1.6B | $674.8M | $1.9B | |
| Net Interest Expenses | $223.9M | $218.3M | $190.2M | $216.7M | $232.1M | |
| EBT. Incl. Unusual Items | $1.1B | $2B | $1.5B | $203M | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $355.7M | $385.9M | $252.8M | $13.2M | $379.7M | |
| Net Income to Company | $1.1B | $2B | $1.5B | $203M | $1.4B | |
| Minority Interest in Earnings | -$112.9M | -$117.8M | -$108.7M | -$54.1M | -$111.9M | |
| Net Income to Common Excl Extra Items | $621.4M | $1.5B | $1.1B | $135.7M | $867.8M | |
| Basic EPS (Cont. Ops) | $0.23 | $0.58 | $0.43 | $0.05 | $0.34 | |
| Diluted EPS (Cont. Ops) | $0.23 | $0.58 | $0.43 | $0.05 | $0.34 | |
| Weighted Average Basic Share | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | |
| Weighted Average Diluted Share | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | |
| EBITDA | $2.3B | $3.3B | $2.8B | $1.6B | $2.7B | |
| EBIT | $1.3B | $2.2B | $1.6B | $418.7M | $1.6B | |
| Revenue (Reported) | $10.9B | $10.3B | $10.8B | $12.9B | $11.1B | |
| Operating Income (Reported) | $1.8B | $1.9B | $1.6B | $674.8M | $1.9B | |
| Operating Income (Adjusted) | $1.3B | $2.2B | $1.6B | $418.7M | $1.6B | |
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10.3B | $10.5B | $11.6B | $12.3B | $11.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.8B | $6.9B | $9.9B | $8.5B | $7.3B | |
| Gross Profit | $3.5B | $3.7B | $1.7B | $3.8B | $4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.6B | $1.8B | $1.9B | $1.7B | $1.8B | |
| Operating Income | $1.9B | $1.8B | -$168.8M | $2.2B | $2.2B | |
| Net Interest Expenses | $225.6M | $203.5M | $188.6M | $227.3M | $248.2M | |
| EBT. Incl. Unusual Items | $2B | $1.8B | -$322.2M | $2B | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $390.8M | $327.5M | -$248.1M | $460.3M | $465M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$116.2M | -$119.7M | -$29.4M | -$129M | -$110.9M | |
| Net Income to Common Excl Extra Items | $1.5B | $1.3B | -$103.5M | $1.4B | $983.1M | |
| Basic EPS (Cont. Ops) | $0.59 | $0.51 | -$0.05 | $0.55 | $0.38 | |
| Diluted EPS (Cont. Ops) | $0.59 | $0.51 | -$0.05 | $0.55 | $0.38 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $3.3B | $3.1B | $1.1B | $3.3B | $2.9B | |
| EBIT | $2.2B | $2B | -$142.9M | $2.2B | $1.8B | |
| Revenue (Reported) | $10.3B | $10.5B | $11.6B | $12.3B | $11.3B | |
| Operating Income (Reported) | $1.9B | $1.8B | -$168.8M | $2.2B | $2.2B | |
| Operating Income (Adjusted) | $2.2B | $2B | -$142.9M | $2.2B | $1.8B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1B | $1.3B | $1B | $544.1M | $663.1M | |
| Short Term Investments | $21.3M | $130.8M | $7.8M | $256K | $767.8K | |
| Accounts Receivable, Net | $1.4B | $1.4B | $1.6B | $1.8B | $1.6B | |
| Inventory | $704M | $754.4M | $759.3M | $820M | $706.4M | |
| Prepaid Expenses | $254.9M | $222.1M | $323.9M | $831.8M | $217.6M | |
| Other Current Assets | $127.9M | $131.4M | $149.5M | $102.9M | $147.3M | |
| Total Current Assets | $3.7B | $4.3B | $4.3B | $4.4B | $3.4B | |
| Property Plant And Equipment | $18.5B | $19.3B | $20B | $19.9B | $20.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.8B | $1.9B | $1.9B | $1.8B | $1B | |
| Other Intangibles | $1.5B | $1.4B | $1.4B | $584M | $612.2M | |
| Other Long-Term Assets | $22.7M | $27M | $53.2M | $45.1M | $51.3M | |
| Total Assets | $28.5B | $30.2B | $30.8B | $30.2B | $29.3B | |
| Accounts Payable | $751.1M | $783.9M | $784.7M | $833.3M | $835.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $12.7M | $28.2M | $27.8M | $29.3M | $25.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.2B | $4.6B | $4.8B | $5.7B | $5.4B | |
| Long-Term Debt | $5B | $5.9B | $6.1B | $6.1B | $5.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $13.1B | $14B | $14.5B | $15.4B | $14.9B | |
| Common Stock | $3B | $3B | $3B | $3B | $3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $14B | $15B | $15B | $14B | $13.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.3B | $1.3B | $1.3B | $807.5M | $788.8M | |
| Total Equity | $15.3B | $16.2B | $16.2B | $14.8B | $14.4B | |
| Total Liabilities and Equity | $28.5B | $30.2B | $30.8B | $30.2B | $29.3B | |
| Cash and Short Terms | $1B | $1.4B | $1B | $544.3M | $663.9M | |
| Total Debt | $6.7B | $7B | $7.5B | $7.6B | $7.4B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $783.3M | $857.2M | $466.5M | $298.4M | $375.1M | |
| Short Term Investments | $271.1M | $247.7M | -- | $3.6M | $2.3M | |
| Accounts Receivable, Net | $1.7B | $2B | $2.3B | $2.1B | $2.1B | |
| Inventory | $735.8M | $728.3M | $844.3M | $748.8M | $776M | |
| Prepaid Expenses | $182.3M | $257.7M | $1.1B | -- | -- | |
| Other Current Assets | $72.8M | $80M | $61.4M | $96.8M | $91.6M | |
| Total Current Assets | $4.1B | $4.5B | $8.1B | $4.2B | $3.9B | |
| Property Plant And Equipment | $18.7B | $19.4B | $18.5B | $19B | $21.1B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.8B | $1.9B | $1.8B | $1.8B | $1B | |
| Other Intangibles | $1.5B | $1.4B | $1.3B | $1.4B | $586.4M | |
| Other Long-Term Assets | $152.1M | $198.2M | $289.7M | $319.3M | $243.8M | |
| Total Assets | $28.9B | $30.3B | $33.2B | $30B | $30B | |
| Accounts Payable | $633.8M | $854.2M | $1.2B | $771.5M | $916.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $23.7M | $28.2M | $28.3M | $28.7M | $20M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.3B | $4.6B | $8.2B | $5.6B | $5.5B | |
| Long-Term Debt | $6.1B | $6B | $6.2B | $6.2B | $6.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $13.6B | $14.1B | $17.9B | $15.2B | $15.5B | |
| Common Stock | $3B | $3B | $3B | $3B | $3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.3B | $1.3B | $1.1B | $792.1M | $777.9M | |
| Total Equity | $15.3B | $16.2B | $15.3B | $14.8B | $14.5B | |
| Total Liabilities and Equity | $28.9B | $30.3B | $33.2B | $30B | $30B | |
| Cash and Short Terms | $1.1B | $1.1B | $466.5M | $302M | $377.4M | |
| Total Debt | $7.3B | $7.3B | $8B | $7.8B | $7.9B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $2B | $1.5B | $203M | $1.4B | |
| Depreciation & Amoritzation | $1B | $1.1B | $1.2B | $1.1B | $1.1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $43.5M | -$18.6M | -$302M | -$446.7M | $234.9M | |
| Change in Inventories | -- | -- | -- | -$159.9M | $47.9M | |
| Cash From Operations | $2.7B | $2.9B | $2.3B | $1.6B | $3B | |
| Capital Expenditures | $1.5B | $1.5B | $1.7B | $2B | $1.7B | |
| Cash Acquisitions | -$55.9M | -$57.5M | -$66.9M | -$259.6M | $174.1M | |
| Cash From Investing | -$743.3M | -$1.3B | -$1.5B | -$2B | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | -$993.2M | -$1B | -$1B | -$1B | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $818.1M | $1.8B | $1B | $2.6B | $733.7M | |
| Long-Term Debt Repaid | -$1.2B | -$1.6B | -$685.6M | -$1.6B | -$746.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$140.6M | -$35.7M | -$89.2M | -$48.3M | -$95.4M | |
| Cash From Financing | -$1.9B | -$1.3B | -$1.1B | -$126M | -$1.7B | |
| Beginning Cash (CF) | $939.9M | $1B | $1.4B | $1B | $543M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $73.6M | $268.4M | -$317.1M | -$464.2M | $121.7M | |
| Ending Cash (CF) | $1B | $1.3B | $1.1B | $542.9M | $661.9M | |
| Levered Free Cash Flow | $1.3B | $1.4B | $543.8M | -$369.8M | $1.3B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.8B | $2.8B | $1.1B | $2.7B | $3.4B | |
| Capital Expenditures | $1.5B | $1.6B | $1.9B | $1.9B | $1.9B | |
| Cash Acquisitions | -$76.3M | $9.9M | -$149.3M | -$9.6M | -$347.3M | |
| Cash From Investing | -$1.2B | -$1.4B | -$1.5B | -$1.6B | -$1.9B | |
| Dividends Paid (Ex Special Dividend) | -$1000M | -$1B | -$1B | -$999.9M | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2B | $558.8M | $2.5B | $1.7B | $481.7M | |
| Long-Term Debt Repaid | -$1.8B | -$576M | -$1.2B | -$1.5B | -$619.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$275M | -$61.5M | -$78.4M | -$81.1M | -$151.5M | |
| Cash From Financing | -$1.4B | -$1.5B | $120.4M | -$1.4B | -$1.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $234.6M | $37.9M | -$271.3M | -$163.5M | $83.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.3B | $1.3B | -$751.7M | $876M | $1.5B | |
| Period Ending | 2021-12-23 | 2022-12-23 | 2023-12-23 | 2024-12-23 | 2025-12-23 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CLPHY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLPHY
Sector
P/E ratio
21.44x
14.18x
PEG ratio
--
0.36x
P/B ratio
1.51x
1.35x
Price / LTM sales
1.84x
1.60x
Growth Metrics
CLPHY
Sector
Revenue growth
--
1.13%
Earnings growth
--
2.03%
Revenue (5-year growth)
-0.93%
4.99%
Earnings forecast
--
$0.43
Profitability
CLPHY
Sector
Profitability FY 2023
$3.6B
$1.5B
Return on invested capital
4.42%
3.64%
Return on assets
3.3%
2.58%
Return on equity
6.75%
8.33%
Earnings Date
Last Earnings Date
Aug
5
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Nov
4
Balance Sheet
CLPHY
Sector
Total cash
$377.4M
$441.3M
Short term investments
$767.8K
$145.7M
Total assets
$29.3B
$12.3B
Long term debt
$7.9B
$3.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
